Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|October 30, 2010
Treatment of diabetes with glucagon-like peptide-1 gene therapyMichael J Riedel, Timothy J Kieffer
Human Genetics|November 27, 2004
Current status of the E23K Kir6.2 polymorphism: implications for type-2 diabetesMichael J Riedel, Diana C Steckley, Peter E Light
American Journal of Physiology. Endocrinology and Metabolism|February 5, 2009
Engineered glucagon-like peptide-1-producing hepatocytes lower plasma glucose levels in miceMichael J Riedel, Corinna Wai Kwan Lee, Timothy J Kieffer
Molecular Endocrinology (Baltimore, Md.)|August 29, 2002
Glucagon-like peptide-1 inhibits pancreatic ATP-sensitive potassium channels via a protein kinase A- and ADP-dependent mechanismPeter E Light, Jocelyn E Manning Fox, Michael J Riedel, et al.
Diabetes|October 26, 2010
Production of functional glucagon-secreting α-cells from human embryonic stem cellsAlireza Rezania, Michael J Riedel, Rhonda D Wideman, et al.
Diabetes|December 12, 2002
The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretionPatrick E MacDonald, Wasim El-Kholy, Michael J Riedel, et al.
Pageof 2